Abstract | OBJECTIVE: DESIGN: Randomised, single blind, clinical trial. SETTING: Acute care unit at Mulago Hospital, Uganda's national referral and teaching hospital in Kampala. PARTICIPANTS: INTERVENTION: Patients were randomised to either intravenous quinine or rectal artemether for seven days. MAIN OUTCOME MEASURES: Time to clearance of parasites and fever; time to regaining consciousness, starting oral intake, and sitting unaided; and adverse effects. RESULTS: The difference in parasitological and clinical outcomes between rectal artemether and intravenous quinine did not reach significance (parasite clearance time 54.2 (SD 33.6) hours v 55.0 (SD 24.3) hours, P = 0.90; fever clearance time 33.2 (SD 21.9) hours v 24.1(SD 18.9 hours, P = 0.08; time to regaining consciousness 30.1 (SD 24.1) hours v 22.67 (SD 18.5) hours, P = 0.10; time to starting oral intake 37.9 (SD 27.0) hours v 30.3 (SD 21.1) hours, P = 0.14). Mortality was higher in the quinine group than in the artemether group (10/52 v 6/51; relative risk 1.29, 95% confidence interval 0.84 to 2.01). No serious immediate adverse effects occurred. CONCLUSION:
|
Authors | Jane Ruth Aceng, Justus S Byarugaba, James K Tumwine |
Journal | BMJ (Clinical research ed.)
(BMJ)
Vol. 330
Issue 7487
Pg. 334
(Feb 12 2005)
ISSN: 1756-1833 [Electronic] England |
PMID | 15705690
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antimalarials
- Artemisinins
- Sesquiterpenes
- Suppositories
- Quinine
- Artemether
|
Topics |
- Administration, Rectal
- Antimalarials
(administration & dosage, adverse effects)
- Artemether
- Artemisinins
(administration & dosage, adverse effects)
- Child
- Child, Preschool
- Humans
- Infant
- Infusions, Intravenous
- Malaria, Cerebral
(drug therapy)
- Parasitemia
(drug therapy)
- Quinine
(administration & dosage, adverse effects)
- Sesquiterpenes
(administration & dosage, adverse effects)
- Single-Blind Method
- Suppositories
- Time Factors
- Treatment Outcome
- Uganda
|